Quantum-Si Incorporated - Ordinary Shares - Class A Stock News

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference.

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the UBS Precision Medicine Frontiers Summit.

Quantum-Si (QSI), a developer of next-generation protein sequencing technology, reported its Q2 2025 earnings on August 5, 2025. The most significant news was a steep revenue shortfall, as GAAP sales came in at $0.59 million compared to analyst estimates of $1.11 million—a miss of nearly 46.7%.

Quantum-Si incorporated (NASDAQ:QSI ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Jeffrey Alan Hawkins - President, CEO & Director Jeffry R. Keyes - CFO & Treasurer Risa Lindsay - Corporate Participant Conference Call Participants Kyle Alexander Mikson - Canaccord Genuity Corp., Research Division Scott Robert Henry - Alliance Global Partners, Research Divisio...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Second Quarter 2025 Financial Results.

Quantum-Si shows bullish technical signals: trading above its 30-week EMA, strong momentum, positive volume trends, and outperforming the S&P 500 since April. Upcoming earnings are a key catalyst. Surpassing $1.28M revenue could trigger a significant rally, while a miss may lead to a sharp sell-off. Despite valuation concerns and NIH funding headwinds, international growth and U.S. non-academic...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the Canaccord Genuity 45th Annual Growth Conference.